Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·10d ago
More News
Zacks.com featured highlights include Maximus, Pediatrix Medical, Sally Beauty and State Street
Zacks highlights Maximus, Pediatrix Medical, Sally Beauty, and State Street as stocks trading near 52-week highs with potential for continued upside.
Zacks·12d ago
4 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run. Stocks like MMS, MD, SBH and STT are seeing price strength, and the momentum is likely to continue.
Zacks·13d ago
Pediatrix Medical Group, Inc. (MD) Soars to 52-Week High, Time to Cash Out?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·13d ago
Down 33.4% YTD, Can Select Medical Stitch Back its Growth Story?
After a 33.4% YTD drop, SEM battles rising costs and weak returns while its rehab unit and valuation keep optimism alive.
Zacks·25d ago
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·1mo ago
Here's Why Pediatrix Medical Shares Are Attracting Investors Now
MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.
Zacks·1mo ago
Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock
Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks·2mo ago
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Zacks·2mo ago
Zacks.com featured highlights include Post Holdings, Pediatrix Medical, Envista and Zions Bancorporation
Post Holdings, Pediatrix, Envista, and Zions Bancorporation hit 52-week highs as growth, cash flow, and upgrades fuel momentum.